A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...
Automated cell therapy manufacturing pioneer Cellares has hit a key milestone, gaining a current Good Manufacturing Practice (cGMP) stamp of approval for its Cell Shuttle factory-in-a-box, which is ...
When most people think of cancer care, they rarely associate it with what goes on behind the scenes to create life-saving treatments. For starters, developing cell and gene therapies is pricey, and ...
A $380 million deal between Bristol Myers Squibb and the start-up Cellares is a sign of growing demand for cell and gene therapy manufacturing services. Cellares raised $255 million in a series C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback